Jean-Charles Fruchart Prize in Nuclear Receptors and Atherosclerosis Research

Jean-Charles Fruchart Prize in Nuclear Receptors and Atherosclerosis Research

Funder: International Atherosclerosis Society (DC, US) and R3i Foundation

Website: https://athero.org/endowed-awards/

Recognition: Prize for outstanding research in nuclear receptors and atherosclerosis

Award Criteria: Recognizes outstanding scientific, medical or organizational advancement in the ability to understand the functional involvement of nuclear receptors in atherosclerotic vascular disease and their athero-protective role to reduce the development of atherosclerosis.

Scope: International recognition

Recent Award Recipients

• 2024 (2nd Prize): Peter Tontonoz, MD, PhD - Awarded at the 20th International Symposium on Atherosclerosis (ISA2024) in Muscat, Oman
• 2021 (1st Prize): Hitoshi Shimano, MD, PhD - Clinical professor of the Department of Internal Medicine, Metabolism and Endocrinology at the University of Tsukuba, Japan. Awarded at ISA2021 in Kyoto, Japan

Sponsorship: Sponsored by the R3i Foundation and the International Atherosclerosis Society